ArticleFrontiers in neurology
Discrepancies in symptom concerns and burden from the perspectives of parkinson's disease patients, caregivers, and physicians.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism.Molecular neurobiology · 2026Article
- What's in a name? reframing advanced Parkinson's disease as a multidimensional state.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Discrepancies in symptom concerns and the perceived burden among individuals with Parkinson's disease (PD), their caregivers, and their physicians can hinder effective care. Objectives: We investigated differences in symptom recognition and perceived impact among these groups. Participants and Methods: We conducted a cross-sectional study involving 193 PD patients, 80 caregivers, and their attending physicians at Keio University Hospital. All independently selected and ranked the three most troublesome symptoms from a comprehensive symptom list. The patients and physicians completed a questionnaire on motor complications including wearing-off, dyskinesia, delayed-on, no-on, and on-off, assessing both their recognition and the perceived burden. Results: Bradykinesia consistently emerged as the most concerning symptom in all three groups. Discrepancies in other symptoms' prioritization were observed. Tremor was more frequently prioritized by patients than by caregivers or physicians. The caregivers tended to emphasize symptoms that directly impacted caregiving, e.g., axial symptoms and non-motor manifestations such as urinary urgency and excessive daytime sleepiness. Motor complications (e.g., wearing-off, dyskinesia) were not highly prioritized by patients, even among those with longer disease durations. The physicians recognized these complications slightly more frequently and rated them as more distressing. Other motor complications, e.g., delayed-on, no-on, and on-off phenomena were more frequently recognized by patients than by their physicians. Conclusion: Significant perceptual gaps exist in the recognition and perceived burden of individual symptoms among PD patients, caregivers, and physicians. Improving communication, raising awareness of under-recognized symptoms, and fostering shared decision-making are essential for optimizing PD patients' individualized care and enhancing quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.